Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy.

Leary M, Heerboth S, Lapinska K, Sarkar S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E483. doi: 10.3390/cancers10120483. Review.


Cancer Progenitor Cells: The Result of an Epigenetic Event?

Lapinska K, Faria G, McGonagle S, Macumber KM, Heerboth S, Sarkar S.

Anticancer Res. 2018 Jan;38(1):1-6. Review.


The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells.

Lapinska K, Housman G, Byler S, Heerboth S, Willbanks A, Oza A, Sarkar S.

Anticancer Res. 2016 Nov;36(11):5731-5742.


The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences.

Willbanks A, Leary M, Greenshields M, Tyminski C, Heerboth S, Lapinska K, Haskins K, Sarkar S.

Genet Epigenet. 2016 Aug 3;8:25-36. doi: 10.4137/GEG.S31863. eCollection 2016. Review.


A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis.

Longacre M, Snyder NA, Housman G, Leary M, Lapinska K, Heerboth S, Willbanks A, Sarkar S.

Int J Mol Sci. 2016 May 18;17(5). pii: E759. doi: 10.3390/ijms17050759. Review.


EMT and tumor metastasis.

Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S.

Clin Transl Med. 2015 Feb 26;4:6. doi: 10.1186/s40169-015-0048-3. eCollection 2015.


Use of epigenetic drugs in disease: an overview.

Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S.

Genet Epigenet. 2014 May 27;6:9-19. doi: 10.4137/GEG.S12270. eCollection 2014. Review.


Drug resistance in cancer: an overview.

Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S.

Cancers (Basel). 2014 Sep 5;6(3):1769-92. doi: 10.3390/cancers6031769. Review.

Supplemental Content

Loading ...
Support Center